Płaskonabłonkowy rak skóry
Diagnostyka i diagnoza
Płaskonabłonkowy rak skóry (SCC) jest drugim najczęstszym nowotworem złośliwym skóry, z roczną zachorowalnością około 1,8 miliona przypadków w USA i wzrostem częstości o 200% w ciągu ostatnich 30 lat. Diagnostyka SCC opiera się na szczegółowym badaniu fizykalnym, wywiadzie uwzględniającym ekspozycję na promieniowanie UV, historię nowotworów skóry oraz stan immunosupresji. Charakterystyczne zmiany kliniczne obejmują szorstkie, łuszczące się czerwone plamy, uniesione guzki, niegojące się owrzodzenia oraz zmiany brodawkowate. W diagnostyce nieinwazyjnej stosuje się dermatoskopię (cechy: skupione kropkowane wzorce naczyniowe, hiperkeratoza), reflektancyjną mikroskopię konfokalną (RCM) oraz trójwymiarowe skanowanie całego ciała. Biopsja skóry pozostaje złotym standardem, umożliwiając potwierdzenie diagnozy, różnicowanie raka in situ od postaci inwazyjnej oraz ocenę agresywności nowotworu. W zależności od wielkości i lokalizacji zmiany stosuje się biopsję zeskrobinową, wycinkową lub całkowite wycięcie zmiany z marginesem zdrowej skóry. Ocena węzłów chłonnych, w tym biopsja aspiracyjna cienkoigłowa i biopsja węzła wartowniczego, jest wskazana przy podejrzeniu przerzutów. Zaawansowane badania obrazowe (CT, MRI, PET, USG) służą do oceny naciekania tkanek i rozprzestrzeniania się raka.
Diagnostyka płaskonabłonkowego raka skóry
Płaskonabłonkowy rak skóry (ang. squamous cell carcinoma, SCC) jest drugim najczęstszym nowotworem złośliwym skóry, ustępując jedynie rakowi podstawnokomórkowemu. Zachorowalność na ten typ nowotworu stale wzrasta, z szacowaną liczbą około 1,8 miliona nowych przypadków diagnozowanych rocznie w Stanach Zjednoczonych. Na przestrzeni ostatnich 30 lat zaobserwowano około 200% wzrost występowania SCC.1 Ze względu na potencjał inwazyjny i możliwość przerzutowania, wczesna i precyzyjna diagnostyka jest kluczowa dla zapewnienia skutecznego leczenia.2
Badanie kliniczne
Proces diagnostyczny płaskonabłonkowego raka skóry zazwyczaj rozpoczyna się od dokładnego badania fizykalnego oraz wywiadu medycznego. Lekarz ocenia podejrzaną zmianę skórną, zwracając szczególną uwagę na jej rozmiar, kształt, kolor, teksturę oraz lokalizację.34 Podczas wywiadu istotne jest zebranie informacji dotyczących:
- Historii ekspozycji na promieniowanie ultrafioletowe (słoneczne i sztuczne)
- Wcześniejszych zachorowań na nowotwory skóry
- Występowania nowotworów skóry w rodzinie
- Przebytych oparzeń słonecznych
- Stanów immunosupresji
Badanie fizykalne powinno obejmować ocenę całej powierzchni skóry oraz okolicznych węzłów chłonnych, szczególnie w przypadkach podejrzenia o postać inwazyjną.6 Zmiany sugerujące płaskonabłonkowy rak skóry mogą przybierać różne formy, w tym:
- Szorstkich lub łuszczących się czerwonych (lub ciemniejszych) plam, które mogą krwawić lub pokrywać się strupem
- Uniesionych guzków lub stwardnień, czasami z centralnym zagłębieniem
- Niegojących się owrzodzeń lub ran
- Zmian przypominających brodawki
Metody diagnostyki obrazowej
W ostatnich latach do diagnostyki płaskonabłonkowego raka skóry wprowadzono nieinwazyjne techniki obrazowania, które zwiększają dokładność rozpoznania, umożliwiają wczesne wykrycie zmian, precyzyjniej określają obszary wymagające biopsji oraz pozwalają na nieinwazyjne monitorowanie leczenia.8
Dermatoskopia
Dermatoskopia jest techniką, która umożliwia oglądanie skóry przy użyciu dermatoskopu – urządzenia z soczewką powiększającą i oświetleniem, pozwalającego na dokładniejszą ocenę zmian skórnych.9 W przypadku płaskonabłonkowego raka skóry charakterystyczne cechy dermatoskopowe to:
- Skupione kropkowane/kłębuszkowe wzorce naczyniowe
- Hiperkeratoza widoczna jako dyskretne żółte łuski
Połączenie tych cech osiąga 98% prawdopodobieństwo diagnostyczne dla SCC.10
Mikroskopia konfokalna odbiciowa
Reflektancyjna mikroskopia konfokalna (RCM) jest zaawansowaną techniką obrazowania pozwalającą na wizualizację naskórka i powierzchniowych warstw skóry właściwej, dostarczając obrazów przypominających badanie histologiczne. Ta nieinwazyjna metoda jest szczególnie pomocna w ocenie zmian w lokalizacjach wrażliwych kosmetycznie lub trudno dostępnych, gdzie biopsja mogłaby być uszkadzająca lub trudna do uzyskania.1112
Vectra 3D Whole Body Photo-Imaging
Ta innowacyjna technika tworzy trójwymiarowy, 360-stopniowy fotograficzny model całego ciała w ciągu kilku sekund, bez użycia promieniowania. Wykorzystując 92 kamery, szybkie skanowanie rejestruje serię obrazów, które pozwalają mapować i analizować skórę. Obraz pokazuje liczbę znamion, ich lokalizację na ciele, kolor i rozmiar, co umożliwia monitorowanie zmian, które mogą wskazywać na rozwój raka skóry.13
Biopsja – metoda diagnostyczna z wyboru
Biopsja skóry pozostaje złotym standardem w diagnostyce płaskonabłonkowego raka skóry. Jest to procedura medyczna, podczas której pobiera się próbkę tkanki z podejrzanej zmiany skórnej w celu zbadania jej pod mikroskopem.1415
Biopsja jest konieczna do:
- Potwierdzenia diagnozy płaskonabłonkowego raka skóry
- Różnicowania pomiędzy rakiem in situ a postacią inwazyjną
- Wykrywania agresywnych wzorców histopatologicznych
- Planowania odpowiedniego leczenia
Dostępne są różne typy biopsji skóry, a wybór metody zależy od rozmiaru i lokalizacji zmiany:17
Biopsja złuszczeniowa (shave biopsy)
Stosowana przede wszystkim w przypadku zmian unoszących się ponad powierzchnię skóry. Polega na zeskrobaniu podejrzanej zmiany elastycznym skalpelem. Należy jednak zaznaczyć, że zbyt powierzchowna biopsja tego typu może prowadzić do błędnej diagnozy, klasyfikując inwazyjny nowotwór jako zmianę przedrakową (rogowacenie słoneczne) lub raka in situ.18
Biopsja sztancowa (punch biopsy)
Wykonywana jest przy użyciu specjalnego narzędzia przypominającego formę do wycinania ciastek. Jest odpowiednia do pobierania próbek z mniejszych zmian, które leżą płasko przy skórze. Zazwyczaj wykorzystuje się sztance o średnicy 2-4 mm, pobierając materiał z najbardziej nieprawidłowo wyglądającej części zmiany.1920
Biopsja wycinkowa (excisional biopsy)
Polega na całkowitym usunięciu podejrzanej zmiany wraz z marginesem zdrowej skóry. Jest to metoda preferowana w przypadku diagnostyki płaskonabłonkowego raka skóry, ponieważ pozwala na ocenę głębokości inwazji oraz innych markerów agresywnego zachowania nowotworu.21 Całkowite wycięcie może być odpowiednią początkową procedurą diagnostyczną dla mniejszych guzów.22
W przypadku zmian pigmentowanych lub budzących jakiekolwiek kliniczne podejrzenie czerniaka, zawsze należy stosować technikę biopsji pełnej grubości.23
Ocena węzłów chłonnych
Choć przerzuty do węzłów chłonnych w przypadku płaskonabłonkowego raka skóry nie są powszechne, w niektórych przypadkach konieczna jest ocena ich stanu:
Badanie palpacyjne
Lekarz bada okoliczne węzły chłonne, wyczuwając ewentualne zgrubienia pod skórą. Wyczuwalne węzły chłonne mogą sugerować rozprzestrzenienie się nowotworu.24
Biopsja cienkoiglowa (FNA)
W przypadku podejrzenia zajęcia węzłów chłonnych można wykonać biopsję aspiracyjną cienkoigłową. Jeśli FNA nie wykryje raka w węźle chłonnym, ale lekarz nadal podejrzewa rozprzestrzenienie się nowotworu, węzeł chłonny może zostać usunięty chirurgicznie w celu badania.25
Biopsja węzła wartowniczego
Biopsja węzła wartowniczego jest stosowana w celu sprawdzenia, czy płaskonabłonkowy rak skóry rozprzestrzenił się do układu limfatycznego. Węzły wartownicze to pierwsze węzły chłonne, które zostałyby zajęte, gdyby nowotwór się rozprzestrzeniał.26
Badania obrazowe przy zaawansowanym raku
W przypadku zaawansowanego płaskonabłonkowego raka skóry lub podejrzenia przerzutów, mogą być zalecane dodatkowe badania obrazowe:2728
Tomografia komputerowa (CT)
Tomografia komputerowa polega na wykonaniu serii zdjęć rentgenowskich, dających przekrojowy obraz ciała. Badanie to jest stosowane do sprawdzenia, czy rak rozprzestrzenił się do węzłów chłonnych lub czy wrósł w kość.29 Jest szczególnie przydatna w określaniu obecności naciekania kości lub tkanek miękkich oraz ocenie szyjnych węzłów chłonnych zagrożonych przerzutami.30
Rezonans magnetyczny (MRI)
MRI tworzy obraz obszaru przy użyciu pola magnetycznego. Podobnie jak CT, daje przekrojowy obraz. Jest to preferowana metoda obrazowania do oceny inwazji okołonerwowej oraz rozszerzenia oczodołowego lub wewnątrzczaszkowego.31
Pozytonowa tomografia emisyjna (PET)
Badania PET są używane do sprawdzenia, czy rak się rozprzestrzenił. Często pacjent przechodzi jednocześnie badanie PET i CT lub MRI.32
Badanie ultrasonograficzne (USG)
USG wykorzystuje fale dźwiękowe o wysokiej częstotliwości. Jest stosowane do sprawdzenia, czy rak rozprzestrzenił się do węzłów chłonnych lub do sprawdzenia węzłów chłonnych po operacji.33
Ocena zaawansowania nowotworu
Po potwierdzeniu diagnozy płaskonabłonkowego raka skóry, konieczne jest określenie stopnia zaawansowania nowotworu, co pomaga w wyborze odpowiedniego leczenia.34
Klasycznie, ocena zaawansowania raka jest przeprowadzana zgodnie z kryteriami TNM (guz, węzły chłonne, przerzuty) Amerykańskiego Wspólnego Komitetu ds. Raka (AJCC).35
System ten klasyfikuje nowotwory skóry, w tym płaskonabłonkowy rak skóry, w następujący sposób:
Guz pierwotny (T)
- TX: Guz pierwotny nie może być oceniony
- T0: Brak dowodów na guz pierwotny
- Tis: Rak in situ
- T1: Guz o średnicy 2 cm lub mniejszy, z mniej niż 2 cechami wysokiego ryzyka
- T2: Guz większy niż 2 cm lub guz dowolnej wielkości z 2 lub więcej cechami wysokiego ryzyka
- T3: Guz z naciekiem na szczękę, żuchwę, oczodół lub kość skroniową
- T4: Guz z naciekiem na szkielet osiowy lub obwodowy lub z naciekiem okołonerwowym podstawy czaszki
Alternatywnym systemem klasyfikacji stosowanym w ocenie zaawansowania płaskonabłonkowego raka skóry jest system klasyfikacji guza szpitala Brigham and Women’s Hospital, który może zapewniać lepszą ocenę prognostyczną dla pacjentów z miejscowym SCC.37
Część płaskonabłonkowych raków skóry jest klasyfikowana jako wysokiego ryzyka. Cechy wysokiego ryzyka obejmują lokalizację na centralnej części twarzy (powieki, nos, wargi i uszy), a także nowotwory, które:38
- Mają głębokość większą niż 2 mm
- Naciekają tkankę podskórną
- Rozrastają się wzdłuż nerwów (naciek okołonerwowy)
- Powstały na bliźnie lub przewlekłym zapaleniu
- Są słabo zróżnicowane pod względem histologicznym
Rola samobadania i profilaktyki
Wczesne wykrycie płaskonabłonkowego raka skóry jest kluczowe dla skutecznego leczenia. Większość przypadków SCC jest identyfikowana podczas samobadania skóry.39
Zaleca się regularne sprawdzanie skóry, aby zauważyć wszelkie zmiany, które mogą wskazywać na rozwój nowotworu:40
- Nowe zmiany skórne
- Zmiany w istniejących znamionach, brodawkach i innych zmianach skórnych
- Niegojące się przez około dwa miesiące rany lub strupy
- Płaskie plamy łuszczące się, które nie ustępują
Regularne samobadanie powinno być uzupełnione corocznymi wizytami u dermatologa, szczególnie w przypadku osób z czynnikami ryzyka, takimi jak:41
- Wcześniejsze występowanie raka skóry
- Ekspozycja na promieniowanie UV (słoneczne lub sztuczne)
- Jasna karnacja skóry
- Osłabiony układ odpornościowy
Osoby, które przeszły już leczenie z powodu raka skóry, mają zwiększone ryzyko wystąpienia kolejnego nowotworu. W takich przypadkach szczególnie ważne są regularne badania kontrolne u dermatologa.42
Podsumowanie diagnostyki
Diagnostyka płaskonabłonkowego raka skóry powinna być kompleksowa i obejmować:
- Dokładne badanie kliniczne skóry i okolicznych węzłów chłonnych
- Wywiad medyczny uwzględniający czynniki ryzyka
- Biopsję podejrzanej zmiany – złoty standard diagnozy
- W przypadku zmian wysokiego ryzyka – dodatkowe badania obrazowe
- Określenie stopnia zaawansowania nowotworu
Wczesna i dokładna diagnostyka płaskonabłonkowego raka skóry jest kluczowa dla skutecznego leczenia i zmniejszenia ryzyka powikłań. Większość przypadków SCC, jeśli zostanie wcześnie wykryta i odpowiednio leczona, ma bardzo dobre rokowanie i wysoki wskaźnik przeżycia.45
Pacjenci z rozpoznanym płaskonabłonkowym rakiem skóry powinni być ściśle monitorowani po początkowej diagnozie, ponieważ istnieje duże prawdopodobieństwo rozwoju kolejnych zmian SCC w następnych miesiącach i latach. Badania wykazują, że ponad 18% pacjentów rozwinie kolejne zmiany SCC w ciągu sześciu miesięcy od początkowego rozpoznania, a do pięciu lat prawie 88% pacjentów będzie miało nawrót tego nowotworu skóry.46
Dowody te przemawiają za ścisłym monitorowaniem pacjentów, w tym rutynową onkologiczną kontrolą przez co najmniej pięć lat po początkowym rozpoznaniu płaskonabłonkowego raka skóry. Zwiększona częstotliwość onkologicznych badań kontrolnych jest wskazana szczególnie u starszych pacjentów oraz osób z bardziej zaawansowanym lub agresywnym SCC.47
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Squamous Cell Carcinoma: What it is, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/17480-squamous-cell-carcinoma
Squamous cell carcinoma is a type of skin cancer caused by an overproduction of squamous cells in your epidermis, the top layer of your skin. Treatment to remove cancer leads to a positive prognosis if the cancer is found and treated early. […] Squamous cell carcinoma (SCC) or cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer after basal cell carcinoma. […] Over 1 million people receive a squamous cell carcinoma diagnosis in the U.S. each year. The rate of SCC has risen about 200% over the past 30 years. […] Your healthcare provider will physically examine the area of your body where you have symptoms, looking specifically at the size, shape and location of the lump or lesion. […] After your physical exam, your healthcare provider might offer tests to confirm a diagnosis, which could include: Skin biopsy: Removing a small sample of the affected tissue to examine it under a microscope. Imaging tests (CT scan or MRI): Your healthcare provider will use an imaging test to identify the size of your carcinoma underneath your skin and to see if it spread to other parts of your body, especially your lymph nodes.
- #2 Cutaneous Squamous Cell Carcinoma – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK441939/
Squamous cell carcinoma is the second most common skin malignancy in the United States, and its incidence steadily rises each year, posing a significant public health concern. […] Timely surveillance, early diagnosis, and prompt treatment are critical to minimize morbidity and mortality risks. […] Diagnosis usually requires a skin biopsy, with advanced cases often necessitating additional imaging and sentinel lymph node biopsy. […] A skin biopsy is necessary to confirm the diagnosis of cutaneous squamous cell carcinoma. Additionally, sentinel lymph node biopsy and/or radiological evaluation for lymph node metastasis with computed tomography or ultrasound is recommended in cases classified as stage T2B-T3 according to the Brigham and Women’s Hospital (BWH) staging system or stage T4 according to the American Joint Committee on Cancer 8th ed. (AJCC-8) staging system.
- #3 Squamous cell carcinoma of the skin – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/diagnosis-treatment/drc-20352486
Tests and procedures used to diagnose squamous cell carcinoma of the skin include: […] A member of your health care team asks about your health history and looks at your skin for signs of squamous cell carcinoma of the skin. […] A biopsy is a procedure to remove a sample of tissue for testing in a lab. A member of your health care team uses a tool to cut away, shave off or punch out some or all of the area of skin that looks unusual. The sample is tested in a lab to see if it is cancer. […] If you have a skin sore that concerns you, make an appointment with a doctor or other health care professional. You may be referred to a doctor who specializes in the diagnosis and treatment of skin conditions, called a dermatologist. […] If you’ve already had skin cancer, you have an increased risk of a second cancer. Talk with your dermatologist about how often to have a skin exam to look for signs of another skin cancer.
- #4 Squamous Cell Carcinoma: What it is, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/17480-squamous-cell-carcinoma
Squamous cell carcinoma is a type of skin cancer caused by an overproduction of squamous cells in your epidermis, the top layer of your skin. Treatment to remove cancer leads to a positive prognosis if the cancer is found and treated early. […] Squamous cell carcinoma (SCC) or cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer after basal cell carcinoma. […] Over 1 million people receive a squamous cell carcinoma diagnosis in the U.S. each year. The rate of SCC has risen about 200% over the past 30 years. […] Your healthcare provider will physically examine the area of your body where you have symptoms, looking specifically at the size, shape and location of the lump or lesion. […] After your physical exam, your healthcare provider might offer tests to confirm a diagnosis, which could include: Skin biopsy: Removing a small sample of the affected tissue to examine it under a microscope. Imaging tests (CT scan or MRI): Your healthcare provider will use an imaging test to identify the size of your carcinoma underneath your skin and to see if it spread to other parts of your body, especially your lymph nodes.
- #5 Squamous Cell Carcinoma – Diagnosis & Disease Informationhttps://www.cancertherapyadvisor.com/ddi/squamous-cell-carcinoma/
Squamous cell carcinoma (SCC) of the skin which is also called squamous cell skin cancer or cutaneous SCC is a cancer that forms in squamous cells in the outer layer of the epidermis, most often in parts of the body exposed to the sun. […] The article emphasizes the importance of a thorough patient history, including sun exposure, medical conditions, medications, and family history, to assess SCC risk. Physical examination should encompass a full-body skin check and lymph node evaluation. Biopsy is the gold standard for diagnosis, and imaging studies can help determine disease extent. […] A presumptive diagnosis of SCC can be made clinically based on the appearance and location of the lesion and the patients history. Histopathologic findings from a biopsy are the gold standard for SCC diagnosis. […] Patients with suspected SCC should receive a full skin examination and lymph node examination. […] A skin biopsy should be performed on all suspicious lesions. […] Although biopsy is sufficient to establish an SCC diagnosis, imaging studies can help determine the extent of the disease.
- #6 Basal and Squamous Cell Skin Cancer Tests | Skin Cancer Biopsy | American Cancer Societyhttps://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/detection-diagnosis-staging/how-diagnosed.html
Most basal and squamous cell skin cancers are brought to a doctors attention because of signs or symptoms a person is having. […] If you have an abnormal area that might be skin cancer, your doctor will examine it and might do tests to find out if it is cancer or some other skin condition. […] If skin cancer is found and theres a chance it might have spread to other areas of the body, other tests might be done as well. […] Usually the first step is for your doctor to ask about your symptoms, such as when the mark first appeared on the skin, if it has changed in size or appearance, and if it has been painful, itchy, or bleeding. […] The doctor may also feel the nearby lymph nodes, which are bean-sized collections of immune system cells under the skin in certain areas. Some skin cancers can spread to lymph nodes. When this happens, the nodes might be felt as lumps under the skin.
- #7 Basal and Squamous Cell Skin Cancer Symptoms | Skin Cancer Signs | American Cancer Societyhttps://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/detection-diagnosis-staging/signs-and-symptoms.html
Skin cancer, including basal and squamous cell skin cancers, often don’t cause bothersome symptoms until they have grown quite large. Then, skin cancer symptoms may include itching, bleeding, or even pain. But if you know what to look for, you can spot signs of skin cancer when its still small and easier to treat. […] In people with lighter-colored skin, squamous cell cancers (SCCs) tend to occur on sun-exposed areas of the body such as the face, ear, neck, lip, and back of the hands. These cancers are less common in people with darker skin color, in whom theyre more likely to appear in areas that arent often exposed to the sun. […] Less often, SCCs can form in the skin of the genital area. They can also develop in scars or skin sores elsewhere. […] These cancers can appear as: Rough or scaly red (or darker) patches, which might crust or bleed; Raised growths or lumps, sometimes with a lower area in the center; Open sores (which may have oozing or crusted areas) that dont heal, or that heal and then come back; Wart-like growths. […] Both basal and squamous cell skin cancers can also develop as a flat area showing only slight changes from normal skin. […] This is why its important to have a doctor check any new or changing skin growths, sores that dont heal, or other areas that concern you.
- #8 Squamous Cell Carcinoma: An Update on Diagnosis and Treatmenthttps://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
Squamous cell carcinoma (SCC) accounts for most nonmelanoma skin cancer-related metastatic disease and deaths. Histopathology and correct surgical excision remain the gold standard for the diagnosis and treatment of SCC; however, new diagnostic imaging techniques such as dermoscopy and reflectance confocal microscopy have increased the diagnostic accuracy in terms of early recognition, better differential diagnosis, more precise selection of areas to biopsy, and noninvasive monitoring of treatments. […] Although histopathology remains the gold standard for the diagnosis of SCC, some noninvasive optical technologies such as dermoscopy and RCM have recently been applied in an attempt to enhance clinical diagnosis accuracy and to obtain an in vivo characterization of the tumor. […] The combination of clustered dotted/glomerular vascular patterns and hyperkeratosis, seen as discrete yellow scales, has previously been shown to achieve 98% diagnostic probability for SCC.
- #9 Diagnosing Basal & Squamous Cell Skin Cancers | NYU Langone Healthhttps://nyulangone.org/conditions/basal-squamous-cell-skin-cancers/diagnosis
NYU Langone doctors diagnose basal and squamous cell skin cancers with a physical exam and the results of biopsy. […] A dermatologist can sometimes tell by looking at the skin whether you might have a basal or squamous cell carcinoma. […] The doctor can also perform dermoscopy, in which he or she examines your skin with a dermatoscope, a device that features a lens that lights and magnifies the skin. […] Any suspicious growths are biopsied, meaning tissue is removed for examination under a microscope. […] A dermatopathologist, a doctor who specializes in identifying skin diseases under a microscope, looks for signs of basal and squamous cell cancers or an actinic keratosis. […] Your doctor may use one of several types of skin biopsies. […] A shave biopsy involves removing a growth that forms a bump on the skin.
- #10 Squamous Cell Carcinoma: An Update on Diagnosis and Treatmenthttps://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
Squamous cell carcinoma (SCC) accounts for most nonmelanoma skin cancer-related metastatic disease and deaths. Histopathology and correct surgical excision remain the gold standard for the diagnosis and treatment of SCC; however, new diagnostic imaging techniques such as dermoscopy and reflectance confocal microscopy have increased the diagnostic accuracy in terms of early recognition, better differential diagnosis, more precise selection of areas to biopsy, and noninvasive monitoring of treatments. […] Although histopathology remains the gold standard for the diagnosis of SCC, some noninvasive optical technologies such as dermoscopy and RCM have recently been applied in an attempt to enhance clinical diagnosis accuracy and to obtain an in vivo characterization of the tumor. […] The combination of clustered dotted/glomerular vascular patterns and hyperkeratosis, seen as discrete yellow scales, has previously been shown to achieve 98% diagnostic probability for SCC.
- #11 Squamous Cell Carcinoma Symptoms & Diagnosis | Baptist Health Miami Cancer Institutehttps://baptisthealth.net/services/cancer-care/miami-cancer-institute/our-approach/adult-cancers/skin-cancers/squamous-cell-carcinoma-of-the-skin/symptoms-and-diagnosis
When youre screened at Miami Cancer Institute, our multidisciplinary experts use a variety of personalized tests depending on whats right for you. This can include: Biopsy to examine tumor tissues to determine the specific kind of cancer present. […] A non-invasive imaging test that uses a low-power laser, without radiation or harm to your skin, to determine whether a biopsy of the skin is necessary. This advanced technology, known as Reflectance Confocal Microscopy (RCM), is especially helpful in cosmetically sensitive or hard-to-reach areas, where a biopsy may be damaging or hard to obtain. […] Vectra 3D Whole Body Photo-Imaging creates a 360-degree, three-dimensional photographic model of your entire body in seconds, without radiation. Using 92 cameras, the quick scan captures a series of images that allows us to map and analyze your skin. The image shows the number of moles, their location on the body, their color and size and can be used to monitor changes that may indicate the development of skin cancer. Armed with this information, our multidisciplinary team can act early to prevent the spread of the cancer.
- #12 Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Uphttps://www.mdpi.com/2072-6694/16/17/2960
Cutaneous squamous cell carcinoma (SCC) is the second most frequent skin cancer, accounting for approximately 20% of all cutaneous malignancies, and with an increasing incidence due to the progressive increment of the average age of life. The diagnosis is usually firstly suspected based on clinical manifestations; however, dermoscopic features may improve diagnostic sensitivity in cases of an uncertain diagnosis and may guide the biopsy, which should be performed to histopathologically prove the tumor. […] The diagnosis of cutaneous SCC is primarily clinical, based on the visual and tactile assessment of the lesion by a healthcare professional. Definitive diagnosis is achieved histologically through biopsy or excision of the lesion, allowing for microscopic examination and confirmation of cancerous cells. In addition to traditional clinical examination and histopathology, several advanced diagnostic aids have emerged, enhancing the accuracy and early detection of non-melanoma skin cancers (NMSCs), including SCC.
- #13 Squamous Cell Carcinoma Symptoms & Diagnosis | Baptist Health Miami Cancer Institutehttps://baptisthealth.net/services/cancer-care/miami-cancer-institute/our-approach/adult-cancers/skin-cancers/squamous-cell-carcinoma-of-the-skin/symptoms-and-diagnosis
When youre screened at Miami Cancer Institute, our multidisciplinary experts use a variety of personalized tests depending on whats right for you. This can include: Biopsy to examine tumor tissues to determine the specific kind of cancer present. […] A non-invasive imaging test that uses a low-power laser, without radiation or harm to your skin, to determine whether a biopsy of the skin is necessary. This advanced technology, known as Reflectance Confocal Microscopy (RCM), is especially helpful in cosmetically sensitive or hard-to-reach areas, where a biopsy may be damaging or hard to obtain. […] Vectra 3D Whole Body Photo-Imaging creates a 360-degree, three-dimensional photographic model of your entire body in seconds, without radiation. Using 92 cameras, the quick scan captures a series of images that allows us to map and analyze your skin. The image shows the number of moles, their location on the body, their color and size and can be used to monitor changes that may indicate the development of skin cancer. Armed with this information, our multidisciplinary team can act early to prevent the spread of the cancer.
- #14 Squamous cell carcinoma of the skin – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/diagnosis-treatment/drc-20352486
Tests and procedures used to diagnose squamous cell carcinoma of the skin include: […] A member of your health care team asks about your health history and looks at your skin for signs of squamous cell carcinoma of the skin. […] A biopsy is a procedure to remove a sample of tissue for testing in a lab. A member of your health care team uses a tool to cut away, shave off or punch out some or all of the area of skin that looks unusual. The sample is tested in a lab to see if it is cancer. […] If you have a skin sore that concerns you, make an appointment with a doctor or other health care professional. You may be referred to a doctor who specializes in the diagnosis and treatment of skin conditions, called a dermatologist. […] If you’ve already had skin cancer, you have an increased risk of a second cancer. Talk with your dermatologist about how often to have a skin exam to look for signs of another skin cancer.
- #15 Squamous Cell Carcinoma: An Update on Diagnosis and Treatmenthttps://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
Diagnosis is routinely confirmed by biopsy, and histological examination will differentiate between in situ and invasive SCC and detect aggressive histopathological growth patterns. […] Once an invasive/aggressive SCC is diagnosed, it must be staged as the risk for metastasis is reported to be approximately 4%, and even 2 to 3 times higher in immunosuppressed individuals. […] Staging of the tumor is classically performed according to the TNM (tumor, node, and metastasis) American Joint Committee on Cancer (AJCC) criteria.
- #16 Squamous Cell Carcinoma: An Update on Diagnosis and Treatmenthttps://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
Diagnosis is routinely confirmed by biopsy, and histological examination will differentiate between in situ and invasive SCC and detect aggressive histopathological growth patterns. […] Once an invasive/aggressive SCC is diagnosed, it must be staged as the risk for metastasis is reported to be approximately 4%, and even 2 to 3 times higher in immunosuppressed individuals. […] Staging of the tumor is classically performed according to the TNM (tumor, node, and metastasis) American Joint Committee on Cancer (AJCC) criteria.
- #17 Diagnosis and Treatment of Basal Cell and Squamous Cell Carcinoma | AAFPhttps://www.aafp.org/pubs/afp/issues/2012/0715/p161.html
Initial tissue sampling for diagnosis of suspected nonmelanoma skin cancer is typically performed using a shave technique if the lesion is raised, or using a 2- to 4-mm punch biopsy of the most abnormal-appearing skin. Complete excision may be an appropriate initial diagnostic procedure for smaller tumors. Pigmented tumors or those eliciting any clinical suspicion of melanoma should always be evaluated using a full-thickness technique. Exfoliative cytology may be considered for evaluation of suspected basal cell carcinoma in patients in whom even a 2-mm punch biopsy would be inappropriate. […] Surgical excision, including Mohs micrographic surgery, is recommended as first-line treatment for most squamous cell carcinoma. Electrodesiccation and curettage or cryotherapy may be considered for smaller, low-risk lesions. Because squamous cell carcinoma is typically sensitive to radiotherapy, this treatment option is recommended for tumors in high-risk, surgically difficult areas and offers favorable cosmetic results early on.
- #18 Squamous Cell Carcinoma Diagnosis | Skin Cancer And Reconstructive Surgery Centerhttps://scarscenter.com/squamous-cell-carcinoma-diagnosis/
Squamous cell carcinoma (SCC) is the second most common skin carcinoma after basal cell carcinoma. […] Diagnosis of squamous cell carcinoma is best made with an incisional biopsy to assess the depth of invasion and other markers of aggressive behavior. […] Although superficial shave biopsies can be diagnostic, a shave that is too superficial can be misdiagnosed as a precancerous (AK) or an in-situ lesion. […] It is imperative to perform a risk assessment of the squamous cell carcinoma being treated to identify the aggressive subtypes.
- #19 Diagnosis and Treatment of Basal Cell and Squamous Cell Carcinoma | AAFPhttps://www.aafp.org/pubs/afp/issues/2012/0715/p161.html
Initial tissue sampling for diagnosis of suspected nonmelanoma skin cancer is typically performed using a shave technique if the lesion is raised, or using a 2- to 4-mm punch biopsy of the most abnormal-appearing skin. Complete excision may be an appropriate initial diagnostic procedure for smaller tumors. Pigmented tumors or those eliciting any clinical suspicion of melanoma should always be evaluated using a full-thickness technique. Exfoliative cytology may be considered for evaluation of suspected basal cell carcinoma in patients in whom even a 2-mm punch biopsy would be inappropriate. […] Surgical excision, including Mohs micrographic surgery, is recommended as first-line treatment for most squamous cell carcinoma. Electrodesiccation and curettage or cryotherapy may be considered for smaller, low-risk lesions. Because squamous cell carcinoma is typically sensitive to radiotherapy, this treatment option is recommended for tumors in high-risk, surgically difficult areas and offers favorable cosmetic results early on.
- #20 Diagnosing Basal & Squamous Cell Skin Cancers | NYU Langone Healthhttps://nyulangone.org/conditions/basal-squamous-cell-skin-cancers/diagnosis
For small growths that lie flat against the skin, physicians may use a tool called a punch, which resembles a tiny cookie cutter. […] For larger growths, a doctor may perform an excisional biopsy. […] A doctor may perform a lymph node biopsy if he or she notices a swollen node near a possible basal or squamous cell carcinoma. […] A doctor may also order a lymph node biopsy if surgery shows that skin cancer has spread to nerves or blood vessels in the area. […] Squamous cell cancer is more likely to spread than the basal cell variety.
- #21 Squamous Cell Carcinoma Diagnosis | Skin Cancer And Reconstructive Surgery Centerhttps://scarscenter.com/squamous-cell-carcinoma-diagnosis/
Squamous cell carcinoma (SCC) is the second most common skin carcinoma after basal cell carcinoma. […] Diagnosis of squamous cell carcinoma is best made with an incisional biopsy to assess the depth of invasion and other markers of aggressive behavior. […] Although superficial shave biopsies can be diagnostic, a shave that is too superficial can be misdiagnosed as a precancerous (AK) or an in-situ lesion. […] It is imperative to perform a risk assessment of the squamous cell carcinoma being treated to identify the aggressive subtypes.
- #22 Diagnosis and Treatment of Basal Cell and Squamous Cell Carcinoma | AAFPhttps://www.aafp.org/pubs/afp/issues/2012/0715/p161.html
Initial tissue sampling for diagnosis of suspected nonmelanoma skin cancer is typically performed using a shave technique if the lesion is raised, or using a 2- to 4-mm punch biopsy of the most abnormal-appearing skin. Complete excision may be an appropriate initial diagnostic procedure for smaller tumors. Pigmented tumors or those eliciting any clinical suspicion of melanoma should always be evaluated using a full-thickness technique. Exfoliative cytology may be considered for evaluation of suspected basal cell carcinoma in patients in whom even a 2-mm punch biopsy would be inappropriate. […] Surgical excision, including Mohs micrographic surgery, is recommended as first-line treatment for most squamous cell carcinoma. Electrodesiccation and curettage or cryotherapy may be considered for smaller, low-risk lesions. Because squamous cell carcinoma is typically sensitive to radiotherapy, this treatment option is recommended for tumors in high-risk, surgically difficult areas and offers favorable cosmetic results early on.
- #23 Diagnosis and Treatment of Basal Cell and Squamous Cell Carcinoma | AAFPhttps://www.aafp.org/pubs/afp/issues/2012/0715/p161.html
Initial tissue sampling for diagnosis of suspected nonmelanoma skin cancer is typically performed using a shave technique if the lesion is raised, or using a 2- to 4-mm punch biopsy of the most abnormal-appearing skin. Complete excision may be an appropriate initial diagnostic procedure for smaller tumors. Pigmented tumors or those eliciting any clinical suspicion of melanoma should always be evaluated using a full-thickness technique. Exfoliative cytology may be considered for evaluation of suspected basal cell carcinoma in patients in whom even a 2-mm punch biopsy would be inappropriate. […] Surgical excision, including Mohs micrographic surgery, is recommended as first-line treatment for most squamous cell carcinoma. Electrodesiccation and curettage or cryotherapy may be considered for smaller, low-risk lesions. Because squamous cell carcinoma is typically sensitive to radiotherapy, this treatment option is recommended for tumors in high-risk, surgically difficult areas and offers favorable cosmetic results early on.
- #24 Basal and Squamous Cell Skin Cancer Tests | Skin Cancer Biopsy | American Cancer Societyhttps://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/detection-diagnosis-staging/how-diagnosed.html
Most basal and squamous cell skin cancers are brought to a doctors attention because of signs or symptoms a person is having. […] If you have an abnormal area that might be skin cancer, your doctor will examine it and might do tests to find out if it is cancer or some other skin condition. […] If skin cancer is found and theres a chance it might have spread to other areas of the body, other tests might be done as well. […] Usually the first step is for your doctor to ask about your symptoms, such as when the mark first appeared on the skin, if it has changed in size or appearance, and if it has been painful, itchy, or bleeding. […] The doctor may also feel the nearby lymph nodes, which are bean-sized collections of immune system cells under the skin in certain areas. Some skin cancers can spread to lymph nodes. When this happens, the nodes might be felt as lumps under the skin.
- #25 Basal and Squamous Cell Skin Cancer Tests | Skin Cancer Biopsy | American Cancer Societyhttps://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/detection-diagnosis-staging/how-diagnosed.html
If the doctor thinks that a suspicious area might be skin cancer, the area (or part of it) will be removed and sent to a lab to be looked at under a microscope. This is called a skin biopsy. […] If an FNA doesn’t find cancer in a lymph node but the doctor still suspects the cancer has spread there, the lymph node may be removed by surgery and examined. […] But if your doctor thinks you might be at risk for the cancer spreading outside the skin, imaging tests such as an MRI or CT scan might be done.
- #26 How Can Cutaneous Squamous Cell Carcinoma Be Diagnosed? – The Waiting Roomhttps://thewaitingroom.karger.com/tell-me-about/how-can-cutaneous-squamous-cell-carcinoma-be-diagnosed/
Sentinel lymph node biopsy is used to see whether your cSCC has spread into your lymphatic system the sentinel nodes are the first lymph nodes that would be affected if your cancer is spreading. […] Previously we have looked at how a biopsy can help confirm a diagnosis. But other tests are sometimes helpful for advanced cSCC. These are the work up or staging tests, and they can help with planning surgery. Or they may be recommended after surgery to see if more treatment is needed. […] A CT scan (or sometimes cat scan) involves taking a series of X-rays to give a cross-sectional picture of the body. CT scans are used to see if cSCC has spread to lymph nodes or has grown into the bone. […] MRI builds up a picture of an area using a magnetic field. Like CT, it gives a cross-sectional picture. […] PET scans are used to see if the cancer has spread. Often a person has a PET scan and CT scan or MRI. […] Ultrasound uses high-frequency sound waves. Its used to see if cancer has spread to the lymph nodes or to check lymph nodes after surgery.
- #27 Basal and Squamous Cell Skin Cancer Tests | Skin Cancer Biopsy | American Cancer Societyhttps://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/detection-diagnosis-staging/how-diagnosed.html
If the doctor thinks that a suspicious area might be skin cancer, the area (or part of it) will be removed and sent to a lab to be looked at under a microscope. This is called a skin biopsy. […] If an FNA doesn’t find cancer in a lymph node but the doctor still suspects the cancer has spread there, the lymph node may be removed by surgery and examined. […] But if your doctor thinks you might be at risk for the cancer spreading outside the skin, imaging tests such as an MRI or CT scan might be done.
- #28 Cutaneous squamous cell carcinoma: Symptoms, Causes, and Treatment â DermNethttps://dermnetnz.org/topics/cutaneous-squamous-cell-carcinoma
How is squamous cell carcinoma diagnosed? Diagnosis of cutaneous SCC is based on clinical features. The diagnosis and histological subtype are confirmed pathologically by diagnostic biopsy or following excision. […] Patients with high-risk SCC may also undergo staging investigations to determine whether it has spread to lymph nodes or elsewhere. These may include: Imaging using ultrasound scan, X-rays, CT scans, MRI scans; Lymph node or other tissue biopsies.
- #29 How Can Cutaneous Squamous Cell Carcinoma Be Diagnosed? – The Waiting Roomhttps://thewaitingroom.karger.com/tell-me-about/how-can-cutaneous-squamous-cell-carcinoma-be-diagnosed/
Sentinel lymph node biopsy is used to see whether your cSCC has spread into your lymphatic system the sentinel nodes are the first lymph nodes that would be affected if your cancer is spreading. […] Previously we have looked at how a biopsy can help confirm a diagnosis. But other tests are sometimes helpful for advanced cSCC. These are the work up or staging tests, and they can help with planning surgery. Or they may be recommended after surgery to see if more treatment is needed. […] A CT scan (or sometimes cat scan) involves taking a series of X-rays to give a cross-sectional picture of the body. CT scans are used to see if cSCC has spread to lymph nodes or has grown into the bone. […] MRI builds up a picture of an area using a magnetic field. Like CT, it gives a cross-sectional picture. […] PET scans are used to see if the cancer has spread. Often a person has a PET scan and CT scan or MRI. […] Ultrasound uses high-frequency sound waves. Its used to see if cancer has spread to the lymph nodes or to check lymph nodes after surgery.
- #30 Cutaneous Squamous Cell Carcinoma Workup: Approach Considerations, Biopsy, Staginghttps://emedicine.medscape.com/article/1965430-workup
A biopsy should be performed for any lesion suspected of being a cutaneous neoplasm. For most lesions, the biopsy can be readily accomplished in the clinic, under local anesthesia. The type of biopsy used depends on the size of the lesion. […] In advanced-stage cSCC, CT scanning or MRI can be helpful in defining the extent of disease. CT scanning is useful for determining the presence of bone or soft tissue invasion and for evaluating cervical lymph nodes at risk for metastasis. For evaluation of perineural invasion and orbital or intracranial extension, MRI is the preferred imaging modality. […] Small skin lesions in noncritical areas may be amenable to excisional biopsy, in which the entire area of concern is removed. This method has the benefit of being diagnostic as well as potentially therapeutic, without the need for a second procedure.
- #31 Cutaneous Squamous Cell Carcinoma Workup: Approach Considerations, Biopsy, Staginghttps://emedicine.medscape.com/article/1965430-workup
A biopsy should be performed for any lesion suspected of being a cutaneous neoplasm. For most lesions, the biopsy can be readily accomplished in the clinic, under local anesthesia. The type of biopsy used depends on the size of the lesion. […] In advanced-stage cSCC, CT scanning or MRI can be helpful in defining the extent of disease. CT scanning is useful for determining the presence of bone or soft tissue invasion and for evaluating cervical lymph nodes at risk for metastasis. For evaluation of perineural invasion and orbital or intracranial extension, MRI is the preferred imaging modality. […] Small skin lesions in noncritical areas may be amenable to excisional biopsy, in which the entire area of concern is removed. This method has the benefit of being diagnostic as well as potentially therapeutic, without the need for a second procedure.
- #32 How Can Cutaneous Squamous Cell Carcinoma Be Diagnosed? – The Waiting Roomhttps://thewaitingroom.karger.com/tell-me-about/how-can-cutaneous-squamous-cell-carcinoma-be-diagnosed/
Sentinel lymph node biopsy is used to see whether your cSCC has spread into your lymphatic system the sentinel nodes are the first lymph nodes that would be affected if your cancer is spreading. […] Previously we have looked at how a biopsy can help confirm a diagnosis. But other tests are sometimes helpful for advanced cSCC. These are the work up or staging tests, and they can help with planning surgery. Or they may be recommended after surgery to see if more treatment is needed. […] A CT scan (or sometimes cat scan) involves taking a series of X-rays to give a cross-sectional picture of the body. CT scans are used to see if cSCC has spread to lymph nodes or has grown into the bone. […] MRI builds up a picture of an area using a magnetic field. Like CT, it gives a cross-sectional picture. […] PET scans are used to see if the cancer has spread. Often a person has a PET scan and CT scan or MRI. […] Ultrasound uses high-frequency sound waves. Its used to see if cancer has spread to the lymph nodes or to check lymph nodes after surgery.
- #33 How Can Cutaneous Squamous Cell Carcinoma Be Diagnosed? – The Waiting Roomhttps://thewaitingroom.karger.com/tell-me-about/how-can-cutaneous-squamous-cell-carcinoma-be-diagnosed/
Sentinel lymph node biopsy is used to see whether your cSCC has spread into your lymphatic system the sentinel nodes are the first lymph nodes that would be affected if your cancer is spreading. […] Previously we have looked at how a biopsy can help confirm a diagnosis. But other tests are sometimes helpful for advanced cSCC. These are the work up or staging tests, and they can help with planning surgery. Or they may be recommended after surgery to see if more treatment is needed. […] A CT scan (or sometimes cat scan) involves taking a series of X-rays to give a cross-sectional picture of the body. CT scans are used to see if cSCC has spread to lymph nodes or has grown into the bone. […] MRI builds up a picture of an area using a magnetic field. Like CT, it gives a cross-sectional picture. […] PET scans are used to see if the cancer has spread. Often a person has a PET scan and CT scan or MRI. […] Ultrasound uses high-frequency sound waves. Its used to see if cancer has spread to the lymph nodes or to check lymph nodes after surgery.
- #34 Squamous Cell Carcinoma: What it is, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/17480-squamous-cell-carcinoma
Your healthcare provider will assign a stage to your diagnosis to identify how much cancer is in your body. Stages help them choose the treatment thats right for you. […] Treatment for squamous cell carcinoma focuses on removing cancer from your body. […] If you have invasive squamous cell carcinoma or if treatment to remove your cancer surgically isnt right for you, your healthcare provider could offer medicine to treat your diagnosis. […] Most cases of squamous cell carcinoma have a positive prognosis and an excellent survival rate if you receive an early diagnosis. Early detection and treatment prevent the tumor from growing and damaging other parts of your body.
- #35 Squamous Cell Carcinoma: An Update on Diagnosis and Treatmenthttps://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
Diagnosis is routinely confirmed by biopsy, and histological examination will differentiate between in situ and invasive SCC and detect aggressive histopathological growth patterns. […] Once an invasive/aggressive SCC is diagnosed, it must be staged as the risk for metastasis is reported to be approximately 4%, and even 2 to 3 times higher in immunosuppressed individuals. […] Staging of the tumor is classically performed according to the TNM (tumor, node, and metastasis) American Joint Committee on Cancer (AJCC) criteria.
- #36 Cutaneous Squamous Cell Carcinoma Workup: Approach Considerations, Biopsy, Staginghttps://emedicine.medscape.com/article/1965430-workup
The TNM staging system for nonmelanoma skin cancers, including cSCC, is as follows: Primary tumor (T) TX: Primary tumor cannot be assessed, T0: No evidence of primary tumor, Tis: Carcinoma in situ, T1: Tumor 2 cm or less that has fewer than 2 high-risk features, T2: Tumor larger than 2 cm or tumor of any size with 2 or more high-risk features, T3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone, T4: Tumor with invasion of axial or appendicular skeleton or perineural invasion of the skull base. […] In early 2010, Milross et al proposed an alternative nodal staging system for metastatic cSCC of the head and neck. This system, called N1S3, stages cSCC on the basis of the number (single or multiple) and size (smaller or larger than 3 cm) of lymph nodes involved, as well as incorporating the parotid as one of the regional levels.
- #37 Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment | AAFPhttps://www.aafp.org/pubs/afp/issues/2020/0915/p339.html
The Brigham and Women’s Hospital tumor classification system can determine the stage of CSCC based on tumor risk factors. The eighth edition of the American Joint Committee on Cancer staging manual adds nodal and metastasis classification, but the Brigham and Women’s Hospital system may provide superior prognostication for patients with localized CSCC. […] National Cancer Care Network guidelines recommend the excision of low-risk primary CSCC with a 4- to 6-mm margin of uninvolved skin around the tumor. Mohs micrographic surgery is an appropriate option for high-risk tumors or tumors in sensitive anatomic locations.
- #38 Squamous Cell Carcinoma Diagnosis | Memorial Sloan Kettering Cancer Centerhttps://www.mskcc.org/cancer-care/types/squamous-cell-carcinoma/diagnosis
Cancer on the central part of the face the eyelids, nose, lips, and ears is considered high risk and has the potential to spread to other parts of the body. High-risk squamous cell carcinoma is also one that: […] The skin cancer experts at MSK can help you find a treatment approach for squamous cell skin cancer no matter what your conditions risk level may be.
- #39 Squamous cell carcinoma (SCC) – symptoms, diagnosis and treatment | healthdirecthttps://www.healthdirect.gov.au/squamous-cell-carcinoma
Squamous cell carcinoma (SCC) is a common type of skin cancer that occurs on your skin in places where you’ve been exposed to sun. […] If you think you might have an SCC, see your doctor. They may send you to see a dermatologist (a skin specialist). […] If you go to a dermatologist, they will examine you and may take a small sample from the sore to test in the lab. This is known as a biopsy. […] Not all sores on your skin are skin cancer. But if you do develop skin cancer, the earlier it is treated, the better your outcome. […] Most people find SCCs by checking their own skin. Check your skin regularly so you notice any changes.
- #40 Squamous cell carcinoma of the skin – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/symptoms-causes/syc-20352480
Make an appointment with a health care professional for a sore or scab that doesn’t heal in about two months or a flat patch of scaly skin that won’t go away. […] Skin cancer that starts in the squamous cells is called squamous cell carcinoma of the skin. […] Squamous cell carcinoma of the skin occurs when the squamous cells in the skin get changes in their DNA. Cells’ DNA holds the instructions that tell cells what to do. The changes tell the squamous cells to multiply quickly. The cells continue living when healthy cells would die as part of their natural life cycle. […] Ultraviolet (UV) radiation causes most of the DNA changes in skin cells. UV radiation can come from sunlight, tanning lamps and tanning beds. […] Most squamous cell carcinomas of the skin can be prevented. To protect yourself: Stay out of the sun during the middle of the day. […] Check your skin often and report changes to your health care team. Look at your skin often for new growths. Look for changes in moles, freckles, bumps and birthmarks.
- #41 Squamous cell carcinoma of the skin – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/diagnosis-treatment/drc-20352486
Tests and procedures used to diagnose squamous cell carcinoma of the skin include: […] A member of your health care team asks about your health history and looks at your skin for signs of squamous cell carcinoma of the skin. […] A biopsy is a procedure to remove a sample of tissue for testing in a lab. A member of your health care team uses a tool to cut away, shave off or punch out some or all of the area of skin that looks unusual. The sample is tested in a lab to see if it is cancer. […] If you have a skin sore that concerns you, make an appointment with a doctor or other health care professional. You may be referred to a doctor who specializes in the diagnosis and treatment of skin conditions, called a dermatologist. […] If you’ve already had skin cancer, you have an increased risk of a second cancer. Talk with your dermatologist about how often to have a skin exam to look for signs of another skin cancer.
- #42 Squamous cell carcinoma of the skin – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/squamous-cell-carcinoma/diagnosis-treatment/drc-20352486
Tests and procedures used to diagnose squamous cell carcinoma of the skin include: […] A member of your health care team asks about your health history and looks at your skin for signs of squamous cell carcinoma of the skin. […] A biopsy is a procedure to remove a sample of tissue for testing in a lab. A member of your health care team uses a tool to cut away, shave off or punch out some or all of the area of skin that looks unusual. The sample is tested in a lab to see if it is cancer. […] If you have a skin sore that concerns you, make an appointment with a doctor or other health care professional. You may be referred to a doctor who specializes in the diagnosis and treatment of skin conditions, called a dermatologist. […] If you’ve already had skin cancer, you have an increased risk of a second cancer. Talk with your dermatologist about how often to have a skin exam to look for signs of another skin cancer.
- #43 Squamous Cell Carcinoma: An Update on Diagnosis and Treatmenthttps://pmc.ncbi.nlm.nih.gov/articles/PMC7319751/
Squamous cell carcinoma (SCC) accounts for most nonmelanoma skin cancer-related metastatic disease and deaths. Histopathology and correct surgical excision remain the gold standard for the diagnosis and treatment of SCC; however, new diagnostic imaging techniques such as dermoscopy and reflectance confocal microscopy have increased the diagnostic accuracy in terms of early recognition, better differential diagnosis, more precise selection of areas to biopsy, and noninvasive monitoring of treatments. […] Although histopathology remains the gold standard for the diagnosis of SCC, some noninvasive optical technologies such as dermoscopy and RCM have recently been applied in an attempt to enhance clinical diagnosis accuracy and to obtain an in vivo characterization of the tumor. […] The combination of clustered dotted/glomerular vascular patterns and hyperkeratosis, seen as discrete yellow scales, has previously been shown to achieve 98% diagnostic probability for SCC.
- #44 Squamous Cell Carcinoma: Diagnosis & Treatment | NewYork-Presbyterianhttps://www.nyp.org/cancer/skin-cancer/squamous-cell-cancer/treatment
How is Squamous Cell Carcinoma Diagnosed? Diagnosis Various tests and procedures are used to diagnose squamous cell carcinoma, each beginning with a physical exam where your doctor will note the size, shape, color, and texture of the area or areas in question. Any bleeding, oozing, or crusting at the site will also be noted. […] If, after this examination, your doctor feels the area in question might be cancerous, a skin biopsy will be performed. During a biopsy, part or all of the area is removed and sent to a lab to be examined for diagnosis. […] Early diagnosis is essential for ensuring that you have the broadest range of treatment options with the lowest risk of complications.
- #45 Squamous Cell Carcinoma: What it is, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/17480-squamous-cell-carcinoma
Your healthcare provider will assign a stage to your diagnosis to identify how much cancer is in your body. Stages help them choose the treatment thats right for you. […] Treatment for squamous cell carcinoma focuses on removing cancer from your body. […] If you have invasive squamous cell carcinoma or if treatment to remove your cancer surgically isnt right for you, your healthcare provider could offer medicine to treat your diagnosis. […] Most cases of squamous cell carcinoma have a positive prognosis and an excellent survival rate if you receive an early diagnosis. Early detection and treatment prevent the tumor from growing and damaging other parts of your body.
- #46 Monitor cutaneous squamous cell carcinoma patients closely after initial diagnosishttps://www.dermatologytimes.com/view/monitor-cutaneous-squamous-cell-carcinoma-patients-closely-after-initial-diagnosis
Cutaneous squamous cell carcinoma (cSCC) patients need close clinical follow-up after being diagnosed with the skin cancer because subsequent cSCC development is likely in the following months and years. […] More than 18% of these patients will develop subsequent SCC lesions within six months of the initial diagnosis. By five years, nearly 88% of patients will have had a recurrence of the skin cancer, according to a recent study in the Journal of the American Academy of Dermatology. […] The evidence supports close patient monitoring, including routine oncologic follow-up for at least five years after the initial cSCC diagnosis. […] The data also supports increasing the frequency of oncologic follow-up for older patients and those presenting with more advanced or aggressive [cSCC], they write.
- #47 Monitor cutaneous squamous cell carcinoma patients closely after initial diagnosishttps://www.dermatologytimes.com/view/monitor-cutaneous-squamous-cell-carcinoma-patients-closely-after-initial-diagnosis
Cutaneous squamous cell carcinoma (cSCC) patients need close clinical follow-up after being diagnosed with the skin cancer because subsequent cSCC development is likely in the following months and years. […] More than 18% of these patients will develop subsequent SCC lesions within six months of the initial diagnosis. By five years, nearly 88% of patients will have had a recurrence of the skin cancer, according to a recent study in the Journal of the American Academy of Dermatology. […] The evidence supports close patient monitoring, including routine oncologic follow-up for at least five years after the initial cSCC diagnosis. […] The data also supports increasing the frequency of oncologic follow-up for older patients and those presenting with more advanced or aggressive [cSCC], they write.